NovelliG., RossiM., PretagostiniR.Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. Transplant Proc2001; 33: 1942–4.
2.
StangeJ., MitznerS.R., KlammtS.Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl2000; 6: 603–13.
3.
HansenE., BucherM., JakobW., LembergerP., KeesF.Pharmacokinetics of levofloxacin during veno-venous hemofiltration. Intens Care Med2001; 27: 371–5.
4.
TraunmüllerF., Thalhammer-ScherrerR., LockerG.Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients. J Antimicrob Chemother2001; 47: 229–31.
5.
BellmannR., EggerP., GritschW.Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther2002; 40: 142–9.
6.
Majcher-PeszynskaJ., PeszynskiP., KlammtS.Elimination of antibiotics by albumin dialysis. Pharmacol Toxicol2001; 89(suppl 1): S88.
